Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-23-099294

CFO, EVP & Treasurer sold 60,743 shares at an average $51.75 ($3,143,195)

  • CFO, EVP & Treasurer acquired 56,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PETERS WILLIAM J CFO, EVP & Treasurer 2023-09-06 Option exercise 10b5-1 +10,000 $19.79 $197,900 115,603 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-09-06 Option exercise 10b5-1 +21,250 $20.23 $429,888 136,853 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-09-06 Option exercise 10b5-1 +25,250 $13.03 $329,008 162,103 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-09-06 Sale 10b5-1 −60,684 $51.75 $3,140,112 101,419 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-09-06 Sale 10b5-1 −59 $52.26 $3,083 101,360 D
Derivatives
PETERS WILLIAM J CFO, EVP & Treasurer 2023-09-06 Option exercise · Employee Stock Option (right to buy) 10b5-1 −10,000 5,053 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-09-06 Option exercise · Employee Stock Option (right to buy) 10b5-1 −21,250 36,475 D
PETERS WILLIAM J CFO, EVP & Treasurer 2023-09-06 Option exercise · Employee Stock Option (right to buy) 10b5-1 −25,250 69,100 D
Open-market sales · 60,743 sh · avg $51.75 · $3,143,195
Loading xslF345X05/tm2325705-1_4seq1.xml…